Millicom International Cellular Valuation
Is M4M1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of M4M1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: M4M1 (€18.9) is trading above our estimate of fair value (€3.99)
Significantly Below Fair Value: M4M1 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for M4M1?
Other financial metrics that can be useful for relative valuation.
What is M4M1's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$3.53b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.8x |
Enterprise Value/EBITDA | 5.4x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does M4M1's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.8x | ||
FNTN freenet | 1.2x | 1.8% | €3.1b |
1U1 1&1 | 0.7x | 2.1% | €2.9b |
UTDI United Internet | 0.6x | 4.0% | €3.9b |
O2D Telefónica Deutschland Holding | 0.8x | -1.2% | €7.0b |
M4M1 Millicom International Cellular | 0.6x | 2.9% | €3.5b |
Price-To-Sales vs Peers: M4M1 is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.8x).
Price to Earnings Ratio vs Industry
How does M4M1's PE Ratio compare vs other companies in the Global Wireless Telecom Industry?
Price-To-Sales vs Industry: M4M1 is good value based on its Price-To-Sales Ratio (0.6x) compared to the Global Wireless Telecom industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is M4M1's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.6x |
Fair PS Ratio | 1.3x |
Price-To-Sales vs Fair Ratio: M4M1 is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | €18.90 | €21.62 +14.4% | 17.0% | €27.96 | €16.78 | n/a | 7 |
Apr ’25 | €18.00 | €21.30 +18.3% | 17.1% | €27.81 | €16.69 | n/a | 7 |
Mar ’25 | €17.00 | €21.28 +25.2% | 16.7% | €27.68 | €16.61 | n/a | 7 |
Feb ’25 | €15.50 | €19.74 +27.3% | 19.4% | €27.66 | €16.59 | n/a | 7 |
Jan ’25 | €16.00 | €18.98 +18.6% | 21.9% | €27.52 | €15.59 | n/a | 7 |
Dec ’24 | €15.10 | €18.21 +20.6% | 22.6% | €27.34 | €15.49 | n/a | 6 |
Nov ’24 | €14.50 | €18.43 +27.1% | 24.5% | €28.39 | €14.99 | n/a | 6 |
Oct ’24 | €14.20 | €18.57 +30.8% | 23.3% | €27.95 | €14.91 | n/a | 6 |
Sep ’24 | €14.30 | €19.30 +35.0% | 21.7% | €27.65 | €14.75 | n/a | 7 |
Aug ’24 | €13.90 | €19.04 +37.0% | 21.6% | €27.21 | €14.29 | n/a | 7 |
Jul ’24 | €13.50 | €20.11 +49.0% | 21.2% | €27.49 | €14.44 | n/a | 6 |
Jun ’24 | €15.30 | €21.18 +38.4% | 17.0% | €27.96 | €16.72 | n/a | 6 |
May ’24 | €16.00 | €20.60 +28.8% | 15.6% | €27.23 | €17.70 | €18.80 | 7 |
Apr ’24 | €16.80 | €21.08 +25.5% | 15.2% | €27.67 | €17.99 | €18.00 | 7 |
Mar ’24 | €18.30 | €21.26 +16.2% | 18.1% | €27.93 | €15.83 | €17.00 | 6 |
Feb ’24 | €15.30 | €19.90 +30.0% | 19.7% | €27.55 | €15.61 | €15.50 | 6 |
Jan ’24 | €11.70 | €19.05 +62.9% | 25.3% | €28.28 | €12.25 | €16.00 | 7 |
Dec ’23 | €12.70 | €19.40 +52.8% | 25.3% | €28.79 | €12.48 | €15.10 | 7 |
Nov ’23 | €10.70 | €19.95 +86.5% | 28.6% | €30.37 | €10.63 | €14.50 | 7 |
Oct ’23 | €11.30 | €22.45 +98.7% | 29.0% | €33.92 | €13.97 | €14.20 | 7 |
Sep ’23 | €13.40 | €23.74 +77.2% | 31.6% | €33.94 | €13.97 | €14.30 | 7 |
Aug ’23 | €15.10 | €29.40 +94.7% | 10.0% | €33.29 | €24.57 | €13.90 | 5 |
Jul ’23 | €13.30 | €28.03 +110.7% | 10.0% | €31.73 | €23.43 | €13.50 | 5 |
Jun ’23 | €15.50 | €35.80 +131.0% | 30.2% | €54.26 | €24.61 | €15.30 | 5 |
May ’23 | €20.60 | €43.64 +111.8% | 18.2% | €55.00 | €34.23 | €16.00 | 5 |
Analyst Forecast: Target price is less than 20% higher than the current share price.